Our news

Europe Supports Autoantibodies as Biomarkers for T1D

29. April 2020

An important letter of support is out! Great to see regulators such as EMA support the work of the C-Path Institute, a key partner of JDRF. Islet autoantibodies can now officially be used as biomarkers in the development of T1D.